80 related articles for article (PubMed ID: 7019227)
1. A preferential binding site for insulin-like growth factor II in human and rat placental membranes.
Daughaday WH; Mariz IK; Trivedi B
J Clin Endocrinol Metab; 1981 Aug; 53(2):282-8. PubMed ID: 7019227
[No Abstract] [Full Text] [Related]
2. Insulin-like growth factor receptors in rat placental membranes.
Pilistine SJ; Moses AC; Munro HN
Endocrinology; 1984 Sep; 115(3):1060-5. PubMed ID: 6086283
[TBL] [Abstract][Full Text] [Related]
3. Different insulin-like growth factor binding species in human placenta and decidua.
Pekonen F; Suikkari AM; Mäkinen T; Rutanen EM
J Clin Endocrinol Metab; 1988 Dec; 67(6):1250-7. PubMed ID: 2461387
[TBL] [Abstract][Full Text] [Related]
4. Ontogeny and characterization of basic somatomedin receptors in rat placenta.
Bhaumick B; Bala RM
Endocrinology; 1985 Feb; 116(2):492-8. PubMed ID: 2981662
[TBL] [Abstract][Full Text] [Related]
5. IGF-II binding on human lymphoid cells: demonstration of a common high affinity receptor for insulin like peptides.
Hintz RL; Thorsson AV; Enberg G; Hall K
Biochem Biophys Res Commun; 1984 Feb; 118(3):774-82. PubMed ID: 6322765
[TBL] [Abstract][Full Text] [Related]
6. Further characterization of human basic-somatomedin: comparison with insulin-like growth factors I and II.
Bhaumick B; Goren HJ; Bala RM
Horm Metab Res; 1981 Sep; 13(9):515-8. PubMed ID: 6271660
[TBL] [Abstract][Full Text] [Related]
7. Ontogeny of growth factor receptors in the human placenta.
Deal CL; Guyda HJ; Lai WH; Posner BI
Pediatr Res; 1982 Oct; 16(10):820-6. PubMed ID: 6292814
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the insulin and somatomedin-C receptors in human placental cell membranes.
Marshall RN; Underwood LE; Voina SJ; Foushee DB; Van Wyk JJ
J Clin Endocrinol Metab; 1974 Aug; 39(2):283-92. PubMed ID: 4370626
[No Abstract] [Full Text] [Related]
9. The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) genes in the human placenta and membranes: evidence for IGF-IGFBP interactions at the feto-maternal interface.
Han VK; Bassett N; Walton J; Challis JR
J Clin Endocrinol Metab; 1996 Jul; 81(7):2680-93. PubMed ID: 8675597
[TBL] [Abstract][Full Text] [Related]
10. Binding of proinsulin and proinsulin conversion intermediates to human placental insulin-like growth factor I receptors.
Gruppuso PA; Frank BH; Schwartz R
J Clin Endocrinol Metab; 1988 Jul; 67(1):194-7. PubMed ID: 2967852
[TBL] [Abstract][Full Text] [Related]
11. Multiplication stimulating activity (MSA) from the BRL 3A rat liver cell line: relation to human somatomedins and insulin.
Rechler MM; Nissley SP; King GL; Moses AC; Van Obberghen-Schilling EE; Romanus JA; Knight AB; Short PA; White RM
J Supramol Struct Cell Biochem; 1981; 15(3):253-86. PubMed ID: 6267316
[TBL] [Abstract][Full Text] [Related]
12. A potential role for endothelin-1 in human placental growth: interactions with the insulin-like growth factor family of peptides.
Fant ME; Nanu L; Word RA
J Clin Endocrinol Metab; 1992 May; 74(5):1158-63. PubMed ID: 1373736
[TBL] [Abstract][Full Text] [Related]
13. Degradation of somatomedins by the thioredoxin system.
Enberg G; Holmgren A
FEBS Lett; 1985 Apr; 183(1):52-4. PubMed ID: 3884381
[TBL] [Abstract][Full Text] [Related]
14. The subunit structures of two distinct receptors for insulin-like growth factors I and II and their relationship to the insulin receptor.
Massagué J; Czech MP
J Biol Chem; 1982 May; 257(9):5038-45. PubMed ID: 6279656
[No Abstract] [Full Text] [Related]
15. Evidence that somatomedin-C is degraded by the kidney and inhibits insulin degradation.
D'Ercole AJ; Decedue CJ; Furlanetto RW; Underwood LE; Van Wyk JJ
Endocrinology; 1977 Aug; 101(2):577-86. PubMed ID: 885118
[No Abstract] [Full Text] [Related]
16. Receptor binding and growth-promoting activity of insulin-like growth factors in human breast cancer cells (T-47D) in culture.
Myal Y; Shiu RP; Bhaumick B; Bala M
Cancer Res; 1984 Dec; 44(12 Pt 1):5486-90. PubMed ID: 6093996
[TBL] [Abstract][Full Text] [Related]
17. Divergence of binding sites, in vitro action, and secretory regulation of the somatomedin peptides, IGF-I and IGF-II.
Daughaday WH
Proc Soc Exp Biol Med; 1982 Jul; 170(3):257-63. PubMed ID: 7045880
[No Abstract] [Full Text] [Related]
18. The expression of insulin-like growth factor and insulin-like growth factor binding protein mRNAs in mouse placenta.
Carter AM; Nygard K; Mazzuca DM; Han VK
Placenta; 2006; 27(2-3):278-90. PubMed ID: 16338473
[TBL] [Abstract][Full Text] [Related]
19. Interactions of insulin-like growth factors I and II and multiplication-stimulating activity with receptors and serum carrier proteins.
Rechler MM; Zapf J; Nissley SP; Froesch ER; Moses AC; Podskalny JM; Schilling EE; Humbel RE
Endocrinology; 1980 Nov; 107(5):1451-9. PubMed ID: 6159199
[TBL] [Abstract][Full Text] [Related]
20. Purification and characterization of a unique high molecular weight form of insulin-like growth factor II.
Gowan LK; Hampton B; Hill DJ; Schlueter RJ; Perdue JF
Endocrinology; 1987 Aug; 121(2):449-58. PubMed ID: 2439316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
